TY - JOUR
T1 - Cardiovascular risk reduction
T2 - The role of antihypertensive treatment
AU - Kaplan, Norman M.
PY - 1991
Y1 - 1991
N2 - The effects of antihypertensive drugs on mortality from stroke, coronary artery disease (CAD), and nonvascular causes have been studied in 14 trials involving more than 37,000 patients. In the treated patients, blood pressure was 5 to 6 mm Hg lower than that in placebo-treated patients, and whereas mortality from stroke was reduced by 42%, CAD mortality was reduced by only 14%. A major reason for this lack of effect on CAD mortality is apparently the adverse effects of the primary drugs used in these trials (diuretics and beta blockers) on glucose tolerance, lipid levels, and insulin resistance. The angiotensin-converting enzyme inhibitors favorably influence many CAD risk factors, and their use can be expected to reduce CAD mortality in patients treated for hypertension.
AB - The effects of antihypertensive drugs on mortality from stroke, coronary artery disease (CAD), and nonvascular causes have been studied in 14 trials involving more than 37,000 patients. In the treated patients, blood pressure was 5 to 6 mm Hg lower than that in placebo-treated patients, and whereas mortality from stroke was reduced by 42%, CAD mortality was reduced by only 14%. A major reason for this lack of effect on CAD mortality is apparently the adverse effects of the primary drugs used in these trials (diuretics and beta blockers) on glucose tolerance, lipid levels, and insulin resistance. The angiotensin-converting enzyme inhibitors favorably influence many CAD risk factors, and their use can be expected to reduce CAD mortality in patients treated for hypertension.
UR - http://www.scopus.com/inward/record.url?scp=13644253029&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=13644253029&partnerID=8YFLogxK
M3 - Article
SN - 0002-9343
VL - 90
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 2 SUPPL.1
ER -